VTCN1 Antikörper
Kurzübersicht für VTCN1 Antikörper (ABIN7120696)
Target
Alle VTCN1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- VTCN1 antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- V-set domain containing T cell activation inhibitor 1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:200-1:2000, IHC: 1:50-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- VTCN1 (V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))
-
Andere Bezeichnung
- VTCN1
-
Hintergrund
-
Synonyms: V-set domain-containing T-cell activation inhibitor 1|B7 homolog 4 (B7-H4)|B7h.5|Immune costimulatory protein B7-H4|Protein B7S1|T-cell costimulatory molecule B7x|VTCN1|B7H4
Background: Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells(Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.
-
Molekulargewicht
- 50-80 kDa
-
Gen-ID
- 79679
-
UniProt
- Q7Z7D3
Target
-